202 related articles for article (PubMed ID: 11686882)
1. The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis.
Hele DJ; Yacoub MH; Belvisi MG
Respir Res; 2001; 2(3):169-83. PubMed ID: 11686882
[TBL] [Abstract][Full Text] [Related]
2. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
[TBL] [Abstract][Full Text] [Related]
3. FK506 combined with GM6001 prevents tracheal obliteration in a mouse model of heterotopic tracheal transplantation.
Li Y; Shu P; Tang L; Yang X; Fan J; Zhang X
Transpl Immunol; 2019 Dec; 57():101244. PubMed ID: 31526865
[TBL] [Abstract][Full Text] [Related]
4. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinase-1 deficiency abrogates obliterative airway disease after heterotopic tracheal transplantation.
Chen P; Farivar AS; Mulligan MS; Madtes DK
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):464-72. PubMed ID: 16388023
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
7. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways.
Hertz MI; Jessurun J; King MB; Savik SK; Murray JJ
Am J Pathol; 1993 Jun; 142(6):1945-51. PubMed ID: 8506960
[TBL] [Abstract][Full Text] [Related]
8. Smad3 deficiency ameliorates experimental obliterative bronchiolitis in a heterotopic tracheal transplantation model.
Ramirez AM; Takagawa S; Sekosan M; Jaffe HA; Varga J; Roman J
Am J Pathol; 2004 Oct; 165(4):1223-32. PubMed ID: 15466388
[TBL] [Abstract][Full Text] [Related]
9. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton TR; Shorthouse R; Huang X; Reitz BA; Morris RE
Transplantation; 1997 Aug; 64(3):373-83. PubMed ID: 9275099
[TBL] [Abstract][Full Text] [Related]
10. A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.
Yang M; Chen G; Zhang X; Ding Z; Miao Y; Yang Y; Chen ZK; Jiang F; Chang S; Zhou P
Transpl Immunol; 2019 Apr; 53():1-6. PubMed ID: 30472390
[TBL] [Abstract][Full Text] [Related]
11. Systemic overexpression of matricellular protein CCN1 exacerbates obliterative bronchiolitis in mouse tracheal allografts.
Raissadati A; Nykänen AI; Tuuminen R; Syrjälä SO; Krebs R; Arnaudova R; Rouvinen E; Wang X; Poller W; Lemström KB
Transpl Int; 2015 Dec; 28(12):1416-25. PubMed ID: 26174800
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model.
McKane BW; Fernandez F; Narayanan K; Marshbank S; Margolin SB; Jendrisak M; Mohanakumar T
Transplantation; 2004 Mar; 77(5):664-9. PubMed ID: 15021826
[TBL] [Abstract][Full Text] [Related]
13. Small animal models of experimental obliterative bronchiolitis.
Jungraithmayr W; Jang JH; Schrepfer S; Inci I; Weder W
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):675-84. PubMed ID: 23392572
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model.
Harris DA; Zhao Y; LaPar DJ; Emaminia A; Steidle JF; Stoler M; Linden J; Kron IL; Lau CL
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):854-61. PubMed ID: 22626514
[TBL] [Abstract][Full Text] [Related]
15. SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.
Mesaki K; Yamane M; Sugimoto S; Fujisawa M; Yoshimura T; Kurosaki T; Otani S; Miyoshi S; Oto T; Matsukawa A; Toyooka S
Surg Today; 2019 May; 49(5):443-450. PubMed ID: 30617600
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model.
Xu J; Torres E; Mora AL; Shim H; Ramirez A; Neujahr D; Brigham KL; Rojas M
J Heart Lung Transplant; 2008 Dec; 27(12):1302-10. PubMed ID: 19059110
[TBL] [Abstract][Full Text] [Related]
17. IL-17 contributes to the pathogenesis of obliterative bronchiolitis via regulation of M1 macrophages polarization in murine heterotopic trachea transplantation models.
Meng Q; Liu J; Lin F; Bao L; Jiang Y; Zheng L; Tie J; Zhang L; Liang X; Wei L; Li Y; Fan H; Zhou X
Int Immunopharmacol; 2017 Nov; 52():51-60. PubMed ID: 28863322
[TBL] [Abstract][Full Text] [Related]
18. Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts.
Ropponen JO; Syrjälä SO; Krebs R; Nykänen A; Tikkanen JM; Lemström KB
J Heart Lung Transplant; 2011 Jun; 30(6):707-16. PubMed ID: 21411341
[TBL] [Abstract][Full Text] [Related]
19. PG490-88, a derivative of triptolide, attenuates obliterative airway disease in a mouse heterotopic tracheal allograft model.
Leonard CT; Soccal PM; Berry GJ; Doyle RL; Theodore J; Duncan SR; Rosen GD
J Heart Lung Transplant; 2002 Dec; 21(12):1314-8. PubMed ID: 12490278
[TBL] [Abstract][Full Text] [Related]
20. Revascularization of the graft in obliterative bronchiolitis after heterotopic tracheal transplantation.
Nemska S; Daubeuf F; Frossard N
Physiol Rep; 2016 Feb; 4(4):. PubMed ID: 26908711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
